Vaxcyte appoints Annie Drapeau and Teri Loxam to board; Heron and Hopfner resign
Vaxcyte, Inc.
Directors Patrick Heron and Rob Hopfner resigned effective Sept 16, 2021, not due to any disagreement.
Annie Drapeau and Teri Loxam appointed as Class I directors with terms expiring at 2024 annual meeting.
Drapeau joins Compensation and Nominating Committees; Loxam joins Audit Committee.
Each new director receives initial option for 30,000 shares vesting over 3 years, annual option for 15,000 shares, and cash retainers ($40,000 base plus committee fees).
On September 16, 2021, Patrick Heron, a director of the Vaxcyte, Inc. (the “Company”) and member of the Audit Committee, and Rob Hopfner, a director of the Company and member of the Nominating and Corporate Governance Committee (the “Nominating Committee”), both resigned as members of the Company’s Board of Directors (the “Board”), which resignations became effective on September 16, 2021.
On September 16, 2021, upon recommendation of the Nominating Committee, the Board appointed Annie Drapeau and Teri Loxam to the Board as Class I directors, which appointments became effective on September 16, 2021.
On September 16, 2021, Patrick Heron, a director of the Vaxcyte, Inc. (the “Company”) and member of the Audit Committee, and Rob Hopfner, a director of the Company and member of the Nominating and Corporate Governance Committee (the “Nominating Committee”), both resigned as members of the Company’s Board of Directors (the “Board”), which resignations became effective on September 16, 2021.
On September 16, 2021, upon recommendation of the Nominating Committee, the Board appointed Annie Drapeau and Teri Loxam to the Board as Class I directors, which appointments became effective on September 16, 2021.
Key facts
Extracted from this filing and checked against the source text.
Executive changeSEC 8-K Item 5.02confidence 0.95
Patrick Heron resigned as Director at Vaxcyte, Inc..
Action
resigned
Role
Director
Exact text from the filing
On September 16, 2021, Patrick Heron, a director of the Vaxcyte, Inc. (the “Company”) and member of the Audit Committee, and Rob Hopfner, a director of the Company and member of the Nominating and Corporate Governance Committee (the “Nominating Committee”), both resigned as members of the Company’s Board of Directors (the “Board”), which resignations became effective on September 16, 2021.
Teri Loxam was appointed as Director at Vaxcyte, Inc..
Action
appointed
Role
Director
Exact text from the filing
On September 16, 2021, upon recommendation of the Nominating Committee, the Board appointed Annie Drapeau and Teri Loxam to the Board as Class I directors, which appointments became effective on September 16, 2021.
Rob Hopfner resigned as Director at Vaxcyte, Inc..
Action
resigned
Role
Director
Exact text from the filing
On September 16, 2021, Patrick Heron, a director of the Vaxcyte, Inc. (the “Company”) and member of the Audit Committee, and Rob Hopfner, a director of the Company and member of the Nominating and Corporate Governance Committee (the “Nominating Committee”), both resigned as members of the Company’s Board of Directors (the “Board”), which resignations became effective on September 16, 2021.
Annie Drapeau was appointed as Director at Vaxcyte, Inc..
Action
appointed
Role
Director
Exact text from the filing
On September 16, 2021, upon recommendation of the Nominating Committee, the Board appointed Annie Drapeau and Teri Loxam to the Board as Class I directors, which appointments became effective on September 16, 2021.
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.